Bellevue Life Sciences Acquisition (BLAC) Institutional Ownership → This Apple-like Innovator is Revolutionizing Healthcare (From Wall Street Star) (Ad) Free BLAC Stock Alerts $10.80 +0.04 (+0.37%) (As of 05/16/2024 09:00 PM ET) Add Compare Share Share OwnershipStock AnalysisChartCompetitorsFinancialsOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisChartCompetitorsFinancialsOwnershipSEC FilingsShort InterestSocial Media Institutional Ownership Changes (13F Filings) for Bellevue Life Sciences Acquisition (NASDAQ:BLAC)CurrentInstitutional OwnershipPercentage55.30%Number ofInstitutional Buyers(last 12 months)22TotalInstitutional Inflows(last 12 months)$30.58MNumber ofInstitutional Sellers(last 12 months)4TotalInstitutional Outflows(last 12 months)$810.96K Get BLAC Insider Trade Alerts Want to know when executives and insiders are buying or selling Bellevue Life Sciences Acquisition stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data BLAC Institutional Buying and Selling by Quarter Ad Manward PressShocking: One AI startup's revenue could surge 4,735%Shocking: One AI Startup's Revenue Could Surge 4,735% While Nvidia gets all the attention, one small AI startup is quietly positioning itself to be the biggest winner.Click here to discover the AI chip company Bellevue Life Sciences Acquisition Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails5/16/2024 Berkley W R Corp322,690$3.44M0.2%N/A5.742% 5/14/2024 K2 Principal Fund L.P.33,589$358K0.1%N/A0.598% 4/18/2024 Wealthspring Capital LLC54,895$585K0.7%-37.3%0.606% 2/13/2024 Karpus Management Inc.86,650$910K0.0%-16.1%0.956% 2/12/2024 Condor Capital Management11,570$121K0.0%N/A0.128% 2/8/2024 Mizuho Securities USA LLC133,495$1.39M0.0%N/A1.473% Get the Latest News and Ratings for BLAC and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Bellevue Life Sciences Acquisition and its competitors with MarketBeat's FREE daily newsletter. 2/8/2024 Cowen AND Company LLC15,750$165K0.0%N/A0.174% 2/1/2024 Wolverine Asset Management LLC183,110$1.92M0.0%+5.8%2.021% 1/17/2024 Schechter Investment Advisors LLC211,227$2.22M0.2%+84.1%2.331% 1/16/2024 Wealthspring Capital LLC87,579$920K1.2%+335.7%0.967% 11/14/2023 AQR Arbitrage LLC449,702$4.68M0.2%+349.7%4.966% 11/14/2023 Robinson Capital Management LLC42,000$438K0.2%N/A0.464% 11/13/2023 Wolverine Asset Management LLC173,110$1.80M0.0%+40.6%1.911% 11/9/2023 Commonwealth of Pennsylvania Public School Empls Retrmt SYS220,723$2.30M0.0%+82.8%2.438% 11/6/2023 Schechter Investment Advisors LLC114,711$1.19M0.1%+277.2%1.267% 11/6/2023 Periscope Capital Inc.615,652$6.40M0.7%+2,175.8%6.799% 10/23/2023 Deltec Asset Management LLC106,248$1.11M0.3%N/A1.173% 10/23/2023 Spartan Fund Management Inc.174,300$1.81M1.4%-12.9%1.924% 10/20/2023 Wealthspring Capital LLC20,100$209K0.4%N/A0.222% 8/15/2023 Bulldog Investors LLP21,620$222K0.1%-8.6%0.239% 8/14/2023 Aristeia Capital LLC165,000$1.69M0.0%+120.0%1.821% 8/14/2023 DLD Asset Management LP70,421$723K0.1%N/A0.777% 8/14/2023 Kim LLC227,693$2.34M0.2%+66.2%2.513% 8/14/2023 Radcliffe Capital Management L.P.150,000$1.54M0.1%N/A1.656% 8/11/2023 Karpus Management Inc.103,250$1.06M0.0%+4.0%1.140% 8/10/2023 Gabelli Funds LLC29,200$300K0.0%N/A0.322% 8/10/2023 GABELLI & Co INVESTMENT ADVISERS INC.20,800$213K0.0%N/A0.230% 8/9/2023 Commonwealth of Pennsylvania Public School Empls Retrmt SYS120,723$1.24M0.0%N/A1.332% 8/7/2023 Wolverine Asset Management LLC123,110$1.26M0.0%+1.3%1.359% 7/31/2023 Spartan Fund Management Inc.200,000$2.05M1.0%N/A2.208% 7/26/2023 Spartan Fund Management Inc.57,173$2.05M1.0%N/A0.631% 5/24/2023 Mint Tower Capital Management B.V.75,000$758K0.0%N/A0.828% 5/12/2023 Periscope Capital Inc.27,052$273K0.0%N/A0.299% 5/12/2023 Clear Street LLC115,264$1.16M0.0%N/A1.273% 5/11/2023 Karpus Management Inc.99,250$1.00M0.0%N/A1.096% 5/11/2023 Kim LLC137,000$1.38M0.1%N/A1.513% 5/10/2023 Mint Tower Capital Management B.V.225,000$777K0.1%N/A2.483% 5/9/2023 Cowen AND Company LLC63,300$639K0.1%N/A0.699% 5/9/2023 Mint Tower Capital Management B.V.225,000$1.53M0.1%N/A2.483% 5/8/2023 Wolverine Asset Management LLC121,585$1.23M0.0%N/A1.342% This Apple-like Innovator is Revolutionizing Healthcare (Ad)AI has infiltrated so many sectors, it's sent the demand for AI-friendly GPU computer chips rocketing. Nvidia has gone up more than 3x in the past year. It is now valued well over $2 trillion, making it one of the largest companies in the world.Click here to learn more about the booming eHealth industry5/5/2023Gritstone Asset Management LLC155,037$1.57M2.0%N/A1.711% (Data available from 1/1/2016 forward) BLAC Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of BLAC shares? During the previous two years, 25 institutional investors and hedge funds held shares of Bellevue Life Sciences Acquisition. The most heavily invested institutionals were Periscope Capital Inc. ($6.40M), AQR Arbitrage LLC ($4.68M), Berkley W R Corp ($3.44M), Kim LLC ($2.34M), Commonwealth of Pennsylvania Public School Empls Retrmt SYS ($2.30M), Schechter Investment Advisors LLC ($2.22M), and Wolverine Asset Management LLC ($1.92M).Learn more on BLAC's institutional investors. What percentage of Bellevue Life Sciences Acquisition stock is owned by institutional investors? 55.30% of Bellevue Life Sciences Acquisition stock is owned by institutional investors. Learn more on BLAC's institutional investor holdings. Which institutional investors have been buying Bellevue Life Sciences Acquisition stock? Of the 24 institutional investors that purchased Bellevue Life Sciences Acquisition stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Periscope Capital Inc. ($615.65K), Mint Tower Capital Management B.V. ($525K), AQR Arbitrage LLC ($349.70K), Berkley W R Corp ($322.69K), Spartan Fund Management Inc. ($257.17K), Kim LLC ($227.69K), and Commonwealth of Pennsylvania Public School Empls Retrmt SYS ($220.72K). How much institutional buying is happening at Bellevue Life Sciences Acquisition? Institutional investors have bought a total of 4,110,062 shares in the last 24 months. This purchase volume represents approximately $42.38M in transactions. Which Bellevue Life Sciences Acquisition major shareholders have been selling company stock? The following institutional investors have sold Bellevue Life Sciences Acquisition stock in the last 24 months: Wealthspring Capital LLC ($32.68K), Spartan Fund Management Inc. ($25.70K), Karpus Management Inc. ($16.60K), and Bulldog Investors LLP ($2.04K). How much institutional selling is happening at Bellevue Life Sciences Acquisition? Institutional investors have sold a total of 77,028 shares in the last 24 months. This volume of shares sold represents approximately $810.96K in transactions. Related Companies: TRON Institutional Ownership IGTA Institutional Ownership NBST Institutional Ownership JVSA Institutional Ownership HHGC Institutional Ownership CCTS Institutional Ownership RFAC Institutional Ownership GMFI Institutional Ownership AFAR Institutional Ownership GTAC Institutional Ownership This page (NASDAQ:BLAC) was last updated on 5/20/2024 by MarketBeat.com Staff From Our PartnersRed Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!Priority GoldDoes this make you sick?Allegiance GoldUrgent Nvidia WarningAltimetryThe Overlooked Retirement Asset You Probably Don’t OwnCrypto 101 MediaThis Apple-like Innovator is Revolutionizing HealthcareWall Street StarShocking: One AI startup's revenue could surge 4,735%Manward PressGlobal crypto currency reset (41 major banks signed up)Stansberry ResearchExposed: 10 CENT Crypto to Explode May 20th?True Market Insiders Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Bellevue Life Sciences Acquisition Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.